Today: 2 July 2026
Browse Category

Mergers & Acquisitions 26 December 2025 - 30 December 2025

DigitalBridge stock jumps nearly 10% on SoftBank’s $4 billion buyout offer — what investors watch next

DigitalBridge stock jumps nearly 10% on SoftBank’s $4 billion buyout offer — what investors watch next

NEW YORK, December 30, 2025, 00:11 ET — Market closed DigitalBridge Group, Inc. shares jumped 9.7% to $15.27 on Monday after SoftBank Group said it would buy the digital infrastructure investor for about $4 billion, or $16 a share in cash. SoftBank said the offer represents a 15% premium to DigitalBridge’s Dec. 26 close and about 50% to the stock’s “unaffected” 52-week average closing price as of Dec. 4. About 86 million shares changed hands, far above recent averages. Nasdaq+1
30 December 2025
···
JNJ stock today: J&J closes $3.05B Halda cancer deal, flags EPS hit — what’s next

JNJ stock today: J&J closes $3.05B Halda cancer deal, flags EPS hit — what’s next

NEW YORK, December 29, 2025, 20:26 ET — Market closed Johnson & Johnson shares were last down 0.02% at $207.56 on Monday after the healthcare conglomerate said it completed its $3.05 billion cash acquisition of cancer drug developer Halda Therapeutics. The stock traded between $207.31 and $209.46, and J&J said it will account for the deal as a business combination and expects it to cut adjusted earnings per share by about $0.20, split evenly between the fourth quarter and 2026. JNJ.com
30 December 2025
····
BP cashes in on Castrol: $10.1 billion Stonepeak deal sets up Castrol India share offer

BP cashes in on Castrol: $10.1 billion Stonepeak deal sets up Castrol India share offer

BP has agreed to sell a 65% stake in its Castrol lubricants business to investment firm Stonepeak, valuing the unit at about $10.1 billion on an enterprise basis. Enterprise value is a measure that includes a company’s debt. Stonepeak BP expects the transaction to deliver net proceeds of around $6 billion, including accelerated dividend payments, and said the cash will be used to reduce net debt. WorkBoat
29 December 2025
··
ServiceNow (NOW) Stock Weekend Update: What Wall Street Is Watching After the $7.75B Armis Deal, CEO Contract Extension, and Fresh Analyst Targets

ServiceNow (NOW) Stock Weekend Update: What Wall Street Is Watching After the $7.75B Armis Deal, CEO Contract Extension, and Fresh Analyst Targets

NEW YORK, Dec. 28, 2025, 10:58 a.m. ET — Market closed New York Stock Exchange ServiceNow, Inc. heads into the final trading stretch of the year with investors still digesting a major strategic pivot: a blockbuster cybersecurity acquisition, a growing list of deals across 2025, and new signals from Wall Street about how much of that M&A premium the market is willing to pay. Reuters+1
28 December 2025
··
ServiceNow (NOW) Stock Today: Analyst Price Targets, Armis Deal Digest, and What to Watch Before Monday’s Open

ServiceNow (NOW) Stock Today: Analyst Price Targets, Armis Deal Digest, and What to Watch Before Monday’s Open

NEW YORK, Dec. 27, 2025, 4:52 p.m. ET — Market closed ServiceNow, Inc. stock is heading into the final stretch of 2025 with Wall Street balancing two competing narratives: a year-end equity backdrop still hovering near record territory, and company-specific debate over whether ServiceNow’s cybersecurity expansion—led by its planned Armis acquisition—adds durable growth or introduces execution and financing risk.
27 December 2025
··
Warner Bros. Discovery Stock (WBD) Weekend Update: Deal-Arbitrage Tension Builds Ahead of Monday’s Open

Warner Bros. Discovery Stock (WBD) Weekend Update: Deal-Arbitrage Tension Builds Ahead of Monday’s Open

NEW YORK, Dec. 27, 2025, 11:09 a.m. ET — Market Closed Warner Bros. Discovery, Inc. — the company behind HBO, Warner Bros. studios and a portfolio of cable networks — heads into the final full week of 2025 with its stock trading less like a traditional media name and more like a live referendum on a high-stakes takeover fight.
27 December 2025
····
Global M&A Boom in 2025: Dealmaking Hits $4.5 Trillion as Trump Antitrust Shift Fuels Megadeals and the Warner Bros Bidding War

Global M&A Boom in 2025: Dealmaking Hits $4.5 Trillion as Trump Antitrust Shift Fuels Megadeals and the Warner Bros Bidding War

Wall Street is ending 2025 the way it likes to start a new year: with phones buzzing, lawyers on standby, and bankers quietly admitting that “holiday break” has become more of an aspiration than a schedule. In the final stretch of December alone, $463.6 billion in mergers and acquisitions were announced, according to Dealogic data cited by Reuters—helping turn the year-end lull into one of the busiest dealmaking periods in recent memory. Reuters
27 December 2025
·
Merck Stock (MRK) News and Forecasts: FDA Fast-Track Vouchers, TrumpRx Pricing Deal, and Cidara Acquisition in Focus Ahead of the Next Market Session

Merck Stock (MRK) News and Forecasts: FDA Fast-Track Vouchers, TrumpRx Pricing Deal, and Cidara Acquisition in Focus Ahead of the Next Market Session

As of 2:34 a.m. ET in New York on Saturday, December 27, 2025, U.S. stock markets are closed for the weekend.Merck & Co., Inc. was last quoted around $106.78, up about 0.33% versus its prior close, based on the latest available pricing feed. With year-end trading under way and liquidity often thinner around the holidays, Merck is heading into the next session with an unusually packed headline stack: policy-driven drug pricing news, FDA review acceleration for two experimental therapies, and portfolio diversification via M&A—all against the backdrop of investors constantly re-litigating the same big question: how Merck replaces Keytruda’s eventual loss of exclusivity later this decade.
27 December 2025
···
WBD Stock Update: Warner Bros. Discovery Shares Hover Near $29 as Netflix Deal, Paramount Bid, and Antitrust Risk Shape the Trade

WBD Stock Update: Warner Bros. Discovery Shares Hover Near $29 as Netflix Deal, Paramount Bid, and Antitrust Risk Shape the Trade

NEW YORK — Dec. 26, 2025 — Warner Bros. Discovery, Inc. Series A Common Stock is heading into the final trading days of the year with a rare combination of forces driving the price: a signed, headline-grabbing deal for its studios and streaming business, a hostile all-cash counterbid for the whole company, and a regulatory review that could determine whether any of it actually closes. Nasdaq WBD ended Friday’s session at $28.80 after a subdued, post-holiday market day on Wall Street. MarketBeat+1 The broader market backdrop was calm—major U.S. indexes finished fractionally lower on light volume, with investors still watching whether a “Santa Claus rally” carries into early January. Reuters
27 December 2025
····
Netflix Stock (NFLX) Today: Shares Tick Higher as Wall Street Weighs Warner Bros. Deal Financing, Regulatory Risk, and Q4 Earnings Ahead

Netflix Stock (NFLX) Today: Shares Tick Higher as Wall Street Weighs Warner Bros. Deal Financing, Regulatory Risk, and Q4 Earnings Ahead

As of 1:05 p.m. ET in New York on Friday, December 26, 2025, Netflix, Inc. is trading at $94.22, up about 0.6% on the day in a quiet, post-holiday session. The broader tape is mixed: the S&P 500 ETF is fractionally lower while the Nasdaq-100 ETF is roughly flat—typical of thin year-end trading where stock-specific headlines can matter more than macro catalysts. Friday’s backdrop is also unusually seasonal: December 26 historically has been one of the market’s more consistently positive calendar days, and it falls inside the “Santa Claus rally” window that traders watch into year-end. MarketWatch
26 December 2025
···
Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

Abivax (ABVX) Stock in Focus: Eli Lilly Takeover Chatter, Obefazimod Phase 3 Momentum, and What to Watch Before the Next U.S. Session

NEW YORK — Friday, December 26, 2025: U.S. stocks are heading into a thin, post‑Christmas trading day, with Wall Street set for a relatively muted open as investors digest a strong 2025 tape and look ahead to 2026 rate and earnings narratives. Reuters In that kind of tape, headline-driven biotech names can swing harder than usual—and ABIVAX Société Anonyme has been exactly that kind of stock in December: a mix of clinical-trial enthusiasm, index-related positioning, and renewed takeover speculation.
26 December 2025
···
1 2 3 … 20

Stock Market Today

  • Analysts Back AI Chip Stocks as 'Screaming Buys' After Pullback
    July 2, 2026, 9:27 AM EDT. Some Wall Street analysts are telling clients to buy into AI chip stocks after a drop from recent highs. They're calling these names 'screaming buys' and say the sector still has major growth potential. Analysts say they expect AI demand to keep growing, even with the market's latest swings.
Go toTop